B-cell depletion in autoimmune diseases

Area of Science:

• Immunology
• Rheumatology
• Oncology

Background:

• B cells play a critical role in autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.
• In autoimmunity, B cells contribute to pathogenesis through antigen presentation, cytokine release, and autoantibody production.

Purpose of the Study:

• To review current therapeutic strategies for B-cell depletion in autoimmune diseases.
• To examine target antigens, efficacy, and limitations of B-cell-targeted therapies.
• To discuss deep B-cell depletion and immunological reset using CAR T cells.

Main Methods:

• Review of current literature on B-cell-targeted therapies for autoimmune diseases.
• Analysis of clinical evidence for monoclonal antibody treatments.
• Discussion of chimeric antigen receptor T-cell therapy concepts.

Main Results:

• Monoclonal antibodies targeting B cells show efficacy in treating autoimmune conditions.
• Challenges include identifying optimal targets and managing treatment limitations.
• Deep B-cell depletion with CAR T cells offers a novel approach for immunological reset.

Conclusions:

• B-cell depletion is a viable therapeutic strategy for autoimmune diseases.
• Further research is needed to optimize B-cell-targeted therapies and overcome challenges.
• CAR T-cell therapy presents a promising avenue for achieving sustained remission.